Discovery of MGS0274, an ester prodrug of a metabotropic glutamate receptor 2/3 agonist with improved oral bioavailability-Reference-Cited by-同舟云学术

Discovery of MGS0274, an ester prodrug of a metabotropic glutamate receptor 2/3 agonist with improved oral bioavailability

Published:2020-10 Issue: Volume:203 Page:112521
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Urabe Hiroki,Miyakoshi Naoki,Ohtake Norikazu,Nozoe Akiko,Ochi Motoki,Fukasawa Misako,Kinoshita Kohnosuke,Yamaguchi Jun-ichi,Marumo Toshiyuki,Hikichi Hirohiko,Chaki Shigeyuki,Hashihayata Takashi

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference23 articles.

1. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia;Lieberman;N. Engl. J. Med.,2005

2. Glutamate and schizophrenia: beyond the dopamine hypothesis;Coyle;Cell. Mol. Neurobiol.,2006

3. Regulation of neurotransmitter release by metabotropic glutamate receptors;Cartmell;J. Neurochem.,2000

4. Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia;Chaki;Eur. J. Pharmacol.,2010

5. Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia;Fell;Neuropharmacology,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates;Chemical Society Reviews;2024

2. Preclinical Metabolism and Disposition of TP0473292, a Novel Oral Prodrug of the Potent Metabotropic Glutamate 2/3 Receptor Antagonist TP0178894 for the Treatment of Depression;Drug Metabolism and Disposition;2023-02-08

3. Bottom-up physiologically based pharmacokinetic modelling for predicting the human pharmacokinetic profiles of the ester prodrug MGS0274 and its active metabolite MGS0008, a metabotropic glutamate 2/3 receptor agonist;Xenobiotica;2022-02-01

4. Prodrug Strategies in the CNS Drugs: Small Modification Makes Big Improvements;Current Topics in Medicinal Chemistry;2021-09

5. Recent developments in predicting CYP-independent metabolism;Drug Metabolism Reviews;2021-05-25